Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins

Dow Jones

05/05

By Colin Kellaher

Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.

Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO.

Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010.

The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board.

Integra said it doesn't plan to initiate a search for a new CEO.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

May 05, 2026 06:49 ET (10:49 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2633491197"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2633491197\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2633491197?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 18:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633491197","market":"hk","top_or_hot":-1,"title":"Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n</p>\n<p>\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n</p>\n<p>\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n</p>\n<p>\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n</p>\n<p>\n  Integra said it doesn't plan to initiate a search for a new CEO. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2026 06:49 ET (10:49 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntegra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-05-05 18:49</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n</p>\n<p>\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n</p>\n<p>\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n</p>\n<p>\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n</p>\n<p>\n  Integra said it doesn't plan to initiate a search for a new CEO. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2026 06:49 ET (10:49 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IART","symbol_name":"英特格拉生命科學","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2633491197","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2633491197","pubTimestamp":1777978140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO.Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010.The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board.Integra said it doesn't plan to initiate a search for a new CEO.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IART":"英特格拉生命科学","BK4082":"医疗保健设备"},"translate_title":"Integra LifeSciences与首席执行官Poul分道扬镳；醋夺回缰绳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IART":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n\n\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n\n\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n\n\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n\n\n  Integra said it doesn't plan to initiate a search for a new CEO. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 06:49 ET (10:49 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}